US Stock MarketDetailed Quotes

KKPCF KAKEN PHARMACEUTICAL

Watchlist
  • 29.199
  • 0.0000.00%
15min DelayClose Dec 9 16:00 ET
1.11BMarket Cap9.54P/E (TTM)

KAKEN PHARMACEUTICAL Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2024
(FY)Mar 31, 2023
(FY)Mar 31, 2022
(FY)Mar 31, 2021
(FY)Mar 31, 2020
(FY)Mar 31, 2019
(FY)Mar 31, 2018
(FY)Mar 31, 2017
(FY)Mar 31, 2016
(FY)Mar 31, 2015
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Net income from continuing operations
43.70%9.8B
-50.90%6.82B
-25.58%13.89B
-29.84%18.66B
6.70%26.59B
-9.98%24.92B
-10.95%27.69B
-11.90%31.09B
89.63%35.29B
20.10%18.61B
Other non cash items
-205.59%-1.4B
717.28%1.32B
-69.94%162M
173.63%539M
59.69%-732M
-218.15%-1.82B
167.80%1.54B
-279.10%-2.27B
-120.61%-598M
314.33%2.9B
Change In working capital
-1,016.05%-5.42B
129.01%592M
-32.10%-2.04B
-124.19%-1.55B
40.13%6.39B
251.03%4.56B
-75.57%-3.02B
49.23%-1.72B
18.82%-3.39B
-315.89%-4.17B
-Change in receivables
-569.03%-4.56B
147.96%972M
-68.67%392M
-85.35%1.25B
187.03%8.54B
158.52%2.98B
-410.57%-5.08B
198.38%1.64B
41.43%-1.66B
-148.89%-2.84B
-Change in inventory
-174.96%-1.6B
-341.91%-583M
108.24%241M
-302.14%-2.92B
-50.65%1.45B
1,990.32%2.93B
92.20%-155M
-93.85%-1.99B
-294.23%-1.03B
84.62%-260M
Cash from discontinued investing activities
Operating cash flow
-72.15%2.58B
-30.62%9.25B
-7.26%13.34B
-47.65%14.38B
30.00%27.47B
-2.64%21.13B
41.60%21.7B
-43.37%15.33B
83.67%27.07B
7.86%14.74B
Investing cash flow
Cash flow from continuing investing activities
Net PPE purchase and sale
5.82%-1.86B
13.45%-1.98B
-107.64%-2.28B
48.93%-1.1B
-12.79%-2.15B
-12.97%-1.91B
22.02%-1.69B
30.67%-2.17B
-23,930.77%-3.12B
99.37%-13M
Net intangibles purchase and sale
-39.73%-306M
19.19%-219M
13.42%-271M
-627.91%-313M
80.45%-43M
-10.55%-220M
-5.85%-199M
-102.15%-188M
-25.68%-93M
-34.55%-74M
Net business purchase and sale
----
----
---4.98B
--0
----
----
----
----
----
----
Net investment purchase and sale
364.62%516M
-4,000.00%-195M
-95.97%5M
2,380.00%124M
600.00%5M
99.92%-1M
-22.96%-1.25B
-35.33%-1.02B
-25,000.00%-753M
0.00%-3M
Net other investing changes
-1,666.39%-4.2B
34.79%-238M
-2.53%-365M
-5.33%-356M
90.65%-338M
-3,375.96%-3.62B
20.00%-104M
3.70%-130M
-123.98%-135M
9,483.33%563M
Cash from discontinued investing activities
Investing cash flow
-122.84%-5.85B
66.70%-2.63B
-379.81%-7.89B
34.97%-1.64B
55.99%-2.53B
-77.01%-5.74B
7.37%-3.25B
14.67%-3.5B
-967.86%-4.11B
122.15%473M
Financing cash flow
Cash flow from continuing financing activities
Net issuance payments of debt
----
----
----
----
---25M
----
----
----
---320M
----
Net common stock issuance
--0
44.49%-1.34B
17.89%-2.41B
30.86%-2.94B
-20.69%-4.25B
-2.26%-3.52B
1.91%-3.45B
-1,647.26%-3.51B
94.47%-201M
-27.13%-3.64B
Cash dividends paid
-0.14%-5.66B
1.14%-5.65B
1.67%-5.71B
1.44%-5.81B
1.75%-5.9B
1.38%-6B
3.23%-6.09B
-15.10%-6.29B
-28.15%-5.46B
-8.31%-4.26B
Net other financing activities
0.00%-1M
0.00%-1M
0.00%-1M
---1M
----
----
----
----
----
0.00%-1M
Cash from discontinued financing activities
Financing cash flow
19.06%-5.66B
14.01%-6.99B
7.12%-8.13B
13.97%-8.75B
-6.81%-10.17B
0.06%-9.52B
2.76%-9.53B
-63.77%-9.8B
24.25%-5.98B
28.13%-7.9B
Net cash flow
Beginning cash position
-0.49%74.26B
-3.47%74.63B
5.43%77.31B
25.22%73.32B
11.12%58.56B
20.40%52.69B
4.85%43.77B
68.55%41.74B
41.87%24.77B
3.17%17.46B
Current changes in cash
-2,354.67%-8.94B
86.42%-364M
-167.29%-2.68B
-73.02%3.98B
151.95%14.77B
-34.35%5.86B
341.11%8.93B
-88.08%2.02B
132.26%16.98B
1,263.81%7.31B
End cash Position
-12.03%65.33B
-0.49%74.26B
-3.47%74.63B
5.43%77.31B
25.22%73.32B
11.12%58.56B
20.40%52.69B
4.85%43.77B
68.55%41.74B
41.87%24.77B
Free cash flow
-94.18%410M
-30.08%7.05B
-16.66%10.08B
-52.13%12.09B
32.97%25.27B
-4.11%19B
52.74%19.82B
-45.61%12.97B
87.66%23.85B
10.16%12.71B
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Mar 31, 2024(FY)Mar 31, 2023(FY)Mar 31, 2022(FY)Mar 31, 2021(FY)Mar 31, 2020(FY)Mar 31, 2019(FY)Mar 31, 2018(FY)Mar 31, 2017(FY)Mar 31, 2016(FY)Mar 31, 2015
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Net income from continuing operations 43.70%9.8B-50.90%6.82B-25.58%13.89B-29.84%18.66B6.70%26.59B-9.98%24.92B-10.95%27.69B-11.90%31.09B89.63%35.29B20.10%18.61B
Other non cash items -205.59%-1.4B717.28%1.32B-69.94%162M173.63%539M59.69%-732M-218.15%-1.82B167.80%1.54B-279.10%-2.27B-120.61%-598M314.33%2.9B
Change In working capital -1,016.05%-5.42B129.01%592M-32.10%-2.04B-124.19%-1.55B40.13%6.39B251.03%4.56B-75.57%-3.02B49.23%-1.72B18.82%-3.39B-315.89%-4.17B
-Change in receivables -569.03%-4.56B147.96%972M-68.67%392M-85.35%1.25B187.03%8.54B158.52%2.98B-410.57%-5.08B198.38%1.64B41.43%-1.66B-148.89%-2.84B
-Change in inventory -174.96%-1.6B-341.91%-583M108.24%241M-302.14%-2.92B-50.65%1.45B1,990.32%2.93B92.20%-155M-93.85%-1.99B-294.23%-1.03B84.62%-260M
Cash from discontinued investing activities
Operating cash flow -72.15%2.58B-30.62%9.25B-7.26%13.34B-47.65%14.38B30.00%27.47B-2.64%21.13B41.60%21.7B-43.37%15.33B83.67%27.07B7.86%14.74B
Investing cash flow
Cash flow from continuing investing activities
Net PPE purchase and sale 5.82%-1.86B13.45%-1.98B-107.64%-2.28B48.93%-1.1B-12.79%-2.15B-12.97%-1.91B22.02%-1.69B30.67%-2.17B-23,930.77%-3.12B99.37%-13M
Net intangibles purchase and sale -39.73%-306M19.19%-219M13.42%-271M-627.91%-313M80.45%-43M-10.55%-220M-5.85%-199M-102.15%-188M-25.68%-93M-34.55%-74M
Net business purchase and sale -----------4.98B--0------------------------
Net investment purchase and sale 364.62%516M-4,000.00%-195M-95.97%5M2,380.00%124M600.00%5M99.92%-1M-22.96%-1.25B-35.33%-1.02B-25,000.00%-753M0.00%-3M
Net other investing changes -1,666.39%-4.2B34.79%-238M-2.53%-365M-5.33%-356M90.65%-338M-3,375.96%-3.62B20.00%-104M3.70%-130M-123.98%-135M9,483.33%563M
Cash from discontinued investing activities
Investing cash flow -122.84%-5.85B66.70%-2.63B-379.81%-7.89B34.97%-1.64B55.99%-2.53B-77.01%-5.74B7.37%-3.25B14.67%-3.5B-967.86%-4.11B122.15%473M
Financing cash flow
Cash flow from continuing financing activities
Net issuance payments of debt -------------------25M---------------320M----
Net common stock issuance --044.49%-1.34B17.89%-2.41B30.86%-2.94B-20.69%-4.25B-2.26%-3.52B1.91%-3.45B-1,647.26%-3.51B94.47%-201M-27.13%-3.64B
Cash dividends paid -0.14%-5.66B1.14%-5.65B1.67%-5.71B1.44%-5.81B1.75%-5.9B1.38%-6B3.23%-6.09B-15.10%-6.29B-28.15%-5.46B-8.31%-4.26B
Net other financing activities 0.00%-1M0.00%-1M0.00%-1M---1M--------------------0.00%-1M
Cash from discontinued financing activities
Financing cash flow 19.06%-5.66B14.01%-6.99B7.12%-8.13B13.97%-8.75B-6.81%-10.17B0.06%-9.52B2.76%-9.53B-63.77%-9.8B24.25%-5.98B28.13%-7.9B
Net cash flow
Beginning cash position -0.49%74.26B-3.47%74.63B5.43%77.31B25.22%73.32B11.12%58.56B20.40%52.69B4.85%43.77B68.55%41.74B41.87%24.77B3.17%17.46B
Current changes in cash -2,354.67%-8.94B86.42%-364M-167.29%-2.68B-73.02%3.98B151.95%14.77B-34.35%5.86B341.11%8.93B-88.08%2.02B132.26%16.98B1,263.81%7.31B
End cash Position -12.03%65.33B-0.49%74.26B-3.47%74.63B5.43%77.31B25.22%73.32B11.12%58.56B20.40%52.69B4.85%43.77B68.55%41.74B41.87%24.77B
Free cash flow -94.18%410M-30.08%7.05B-16.66%10.08B-52.13%12.09B32.97%25.27B-4.11%19B52.74%19.82B-45.61%12.97B87.66%23.85B10.16%12.71B
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Meritage Homes
MTH
+1.78%

Unlock the Full List